Climb Bio, Inc. (CLYM) vs Nuvectis Pharma, Inc. (NVCT)
- Climb Bio, Inc. CLYM 9.82 −9.99%
- Nuvectis Pharma, Inc. NVCT 18.48 −2.38%
Climb Bio, Inc. and Nuvectis Pharma, Inc. are both Biotechnology companies. Climb Bio, Inc. and Nuvectis Pharma, Inc. are of similar size ($626.6M and $618.0M). Across the 9 metrics below, Climb Bio, Inc. leads on 5 and Nuvectis Pharma, Inc. on 4.
Valuation
Profitability
| Metric | CLYM | NVCT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (27.10%) | (233.30%) | (56.36%) |
| Return on assets | (26.27%) | (122.61%) | (48.04%) |
| Return on invested capital | (71.73%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack